FdaApplication
NDA 219164
Identifiers
- fda_app_no: NDA219164
Properties
| Property | Value |
|---|---|
| applicant_name | ASCENDIS PHARMA GROWTH DISORDERS AS |
| application_type | NDA |
| approval_date | 2026-02-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| YUVIWEL | NAVEPEGRITIDE | 2.8MG/VIAL | POWDER;SUBCUTANEOUS |
| YUVIWEL | NAVEPEGRITIDE | 1.3MG/VIAL | POWDER;SUBCUTANEOUS |
| YUVIWEL | NAVEPEGRITIDE | 5.5MG/VIAL | POWDER;SUBCUTANEOUS |
3 products